Announced Sat, 27 Jun · 14:16 IST
Trading window closed for Q1 FY27 results period
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-7.3%1-day move
₹9.70
prior close
₹9.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.6———-7.3-8.6-7.8-8.7-12.5-16.7-19.5———
Up moveDown movePending
AI summary
Indrayani Biotech has informed BSE that the trading window for directors, designated persons and their immediate relatives will be closed from July 1, 2026 until 48 hours after declaration of unaudited financial results for the quarter ending June 30, 2026. The company has also updated the NSDL portal to freeze PANs of designated persons per SEBI circular. Board meeting date for Q1 results will be intimated later.
Likely market impact
Routine quarterly insider trading compliance filing. No direct impact on shareholders. Watch for upcoming Q1 FY27 results declaration.